Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - Potassium Channel - BMS-813160

BMS-813160

CAS No. 1286279-29-5

BMS-813160 ( —— )

Catalog No. M17924 CAS No. 1286279-29-5

BMS-813160 is the first dualCCR2/CCR5antagonist to enter Clinical development for cardiovascular.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 125 In Stock
10MG 177 In Stock
25MG 323 In Stock
50MG 537 In Stock
100MG 767 In Stock
500MG 1557 In Stock
1G Get Quote In Stock
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    BMS-813160
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-813160 is the first dualCCR2/CCR5antagonist to enter Clinical development for cardiovascular.
  • Description
    BMS-813160 is the first dualCCR2/CCR5antagonist to enter Clinical development for cardiovascular.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    CCR2;CCR5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1286279-29-5
  • Formula Weight
    484.64
  • Molecular Formula
    C25H40N8O2
  • Purity
    98%
  • Solubility
    DMSO : 25 mg/mL 51.58 mM;
  • SMILES
    CC(C)(C)N[C@@H]1CC[C@@H]([C@H](NC(C)=O)C1)N4CC[C@H](Nc2ncnc3cc(nn23)C(C)(C)C)C4=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Norman P. et al. A dual CCR2/CCR5 chemokine antagonist, BMS-813160 Evaluation of WO2011046916. Expert Opin Ther Pat. 2011 Dec;21(12):1919-24.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • XE 991 dihydrochlori...

    A potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively.

  • MK-0448

    MK-0448 is a potent, specific I(Kur) current/Kv1.5 channel inhibitor with IC50 of 8.6 nM, potently inhibits IKur in human atrial myocytes with IC50 of 10.8 nM.

  • GSK369796 Dihydrochl...

    GSK369796 Dihydrochlorideis an anti-malaria drug candidate.?is an affordable and effective antimalarial and inhibits hERG potassium ion channel repolarization(IC50 of 7.5 μM)

Sign In Join Free